Amarin Corp Plc (AMRN)

[sts66]

No statins have patent protection left except Kowa's Livalo, so no need for AMRN to license a statin patent from anyone. Otherwise, you're correct - GILD wanting to combine V with another drug would require them licensing rights from AMRN - would also extend protection from generic V for that combo use.